Vaccines University of Rwanda, EU-Delegation MAV+, and vaccine uptake
: SE-0-SE-6-16785This website displays open data about Swedish aid, which shows when, to whom and for what purpose Swedish aid is paid out, as well as what results it has produced. This page contains information about one of the contributions financed with Swedish aid.
Overview
Contributions to strengthen capacity for vaccine development and production in Rwanda. The main contribution is the implementation of the EU's Global Gateway program Team Europe Initiative "MAV+" with the objective of strengthening capacity for vaccine development and production in Rwanda, in collaboration with the University of Rwanda and three Swedish universities, as well as a smaller program with the University of Rwanda for vaccine acceptance research.
Involved parties
- C01 - Project-type interventions
Strategies governing the contribution
Geographical allocation of the contribution
No countries have been assigned to this contribution.
Development areas for the contribution
No development areas have been assigned to this contribution.
Duration of the contribution
Committed and disbursed amount
Paid per year (net value)
- 2025: SEK 390,647
Sustainable Development Goals
The contributions contribution to the UN's global sustainability goals.
